Dar es Salaam. The market value of the domestic firms listed on the Dar es Salaam Stock Exchange (DSE) increased by Sh121 billion last week, thanks to a significant price increase on three domestic counters.
The bourse’s total domestic market capitalisation improved to Sh10.843 trillion last week from Sh10.722 trillion previously, according to analysis by a brokerage firm Vertex International Securities Ltd.
Swissport stock price went up by 12.7 percent to close at Sh1,420 per share, followed by Tanga Cement Company Limited (TCCL) which gained by 6.78 percent to Sh1,260 while CRDB Bank Plc gained by 3.3 percent to Sh470.
“There were no losing domestic counters this week,” Vertex analyses.
Vertex’s capital markets manager Mr Ahmed Nganya said; “We forecast a positive performance next week as we expect this week’s positive price momentum to continue and therefore provide a boost for both volume and turnover.”
The market weekly turnover dropped by 48.5 percent to Sh675.29 million last week from Sh1.31 billion that was recorded in the previous week.
CRDB accounted for 53.32 percent of the total market turnover followed by NMB with 21.7 percent and TCCL with 11.75 percent.
At the end of the trading session on Friday, the Tanzania Shares Index (TSI) which tracks the performance of the local firms, was up by 1.13 percent to close at 4, 102.15 points.
The total market capitalization was up by 2.15 percent to close at Sh15.77 trillion.
In the secondary bond market, the bourse recorded 25 deals from both treasury and corporate bonds with a total turnover of Sh46.36 billion.
The 25-year Treasury bond recorded an average yield of 12.91 percent with an average price of 99.43 percent, followed by the 20-year Treasury bonds with an average yield of 13.45 percent and price of 114.77 percent.
The 15-year Treasury bond recorded an average yield of 10.92 percent and the average cost of 118.59 percent while the 7-year Treasury bond recorded an average yield of 7.98 percent and the average price of 105.67 percent.
Share this news
This Year's Most Read News Stories
Muslims in Pemba conduct special prayer against ZAA decision
ZANZIBAR: More than 200 Muslims in Vitongoji Village, South Pemba Region over the weekend conducted a special prayer to condemn the Zanzibar Airports Authority (ZAA) move to appoint DNATA as the sole ground handler in Terminal III of the International Airport of Zanzibar. Abeid Amani Karume.Continue Reading
New lawsuit as Zanzibar airport controversy continues
Another company joins the list as they file a petition challenging the exclusive rights granted to Dnata by Zanzibar Airports Authority.Continue Reading
Tanzania Confirms Outbreak of Marburg Virus Disease
Dodoma — Tanzania today confirmed an outbreak of Marburg virus disease in the northwestern Kagera region after one case tested positive for the virus following investigations and laboratory analysis of suspected cases of the disease.
President of the Republic of Tanzania, Her Excellency Samia Suluhu Hassan, made the announcement during a press briefing alongside World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus, in the country’s administrative capital Dodoma.
“Laboratory tests conducted in Kabaile Mobile Laboratory in Kagera and later confirmed in Dar es Salaam identified one patient as being infected with the Marburg virus. Fortunately, the remaining suspected patients tested negative,” the president said. “We have demonstrated in the past our ability to contain a similar outbreak and are determined to do the same this time around.”
A total of 25 suspected cases have been reported as of 20 January 2025, all of whom have tested negative and are currently under close follow-up, the president said. The cases have been reported in Biharamulo and Muleba districts in Kagera.
“We have resolved to reassure the general public in Tanzania and the international community as a whole of our collective determination to address the global health challenges, including the Marburg virus disease,” said H.E President Hassan.
WHO is supporting Tanzanian health authorities to enhance key outbreak control measures including disease surveillance, testing, treatment, infection prevention and control, case management, as well as increasing public awareness among communities to prevent further spread of the virus.
“WHO, working with its partners, is committed to supporting the government of Tanzania to bring the outbreak under control as soon as possible, and to build a healthier, safer, fairer future for all the people of Tanzania,” said Dr Tedros. “Now is a time for collaboration, and commitment, to protecting the health of all people in Tanzania, and the region, from the risks posed by this disease.”
Marburg virus disease is highly virulent and causes haemorrhagic fever. It belongs to the same family as the virus that causes Ebola virus disease. Illness caused by Marburg virus begins abruptly. Patients present with high fever, severe headache and severe malaise. They may develop severe haemorrhagic symptoms within seven days.
“The declaration by the president and the measures being taken by the government are crucial in addressing the threat of this disease at the local and national levels as well as preventing potential cross-border spread,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “Our priority is to support the government to rapidly scale up measures to effectively respond to this outbreak and safeguard the health of the population,”
Tanzania previously reported an outbreak of Marburg in March 2023 – the country’s first – in Kagera region, in which a total of nine cases (eight confirmed and one probable) and six deaths were reported, with a case fatality ratio of 67%.
Sign up for free AllAfrica Newsletters
Get the latest in African news delivered straight to your inbox
In the African region, previous outbreaks and sporadic cases have been reported in Angola, the Democratic Republic of the Congo, Ghana, Kenya, Equatorial Guinea, Rwanda, South Africa and Uganda.
Marburg virus is transmitted to people from fruit bats and spreads among humans through direct contact with the bodily fluids of infected people, surfaces and materials. Although several promising candidate medical countermeasures are currently undergoing clinical trials, there is no licensed treatment or vaccine for effective management or prevention of Marburg virus disease. However, early access to treatment and supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improve survival.
Source: allafrica.com
